$2M to the MUHC Foundation for precision cancer care
BMO gift will help cancer researchers at the RI-MUHC develop the hospital’s precision oncology program
RI-MUHC research team leads new consortium to make healthcare data more accessible
The new Quebec SmartCare Consortium has received $10M to break down data silos and increase the...
FANCI: a new gene at the origin of some cases of ovarian cancer
For the first time, researchers link mutations in the FANCI gene to the risk of developing ovarian cancer
RI-MUHC trainee Prisca Bustamante honoured by Mitacs Award for Outstanding Innovation
Doctoral student develops world's first non-invasive blood screening test for uveal melanoma
RI-MUHC study shows impact of combinatorial immunotherapy on an aggressive cancer
A combinatorial immunotherapy may provide significant therapeutic benefit in managing pancreatic ductal...
Morag Park: winner of the “100 Years of Research” prize
Two researchers receive $500,000 to fight metastatic breast cancer
The 2021 RI-MUHC Annual Report is online!
An invitation from Dr. Rhian Touyz
$1.2 million awarded to RI-MUHC researchers in cancer
Dr. Lorenzo Ferri is the principal investigator on a new grant to study esophageal adenocarcinoma
Promising development in the fight with cancer using artificial intelligence
New privacy-preserving approach uses hospital based medical notes to refine predictions and prognosis in cancer...
New G protein inhibitor identified, with potential for cancer therapies
RI-MUHC team publishes study in Nature Communications describing a novel molecule that inhibits growth of cancer cells